Investing.com - Takeda Pharma ADR reported on Tuesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Takeda Pharma ADR announced earnings per share of $0.255 on revenue of $7.25B. Analysts polled by Investing.com anticipated EPS of $0.2973 on revenue of $7.44B.
Takeda Pharma ADR shares are down 29.12% from the beginning of the year and are trading at $16.90 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Takeda Pharma ADR shares lost 0.35% in pre-market trade the report.
Takeda Pharma ADR follows other major sector earnings this month
Takeda Pharma ADR's report follows an earnings beat by Industrial Commercial Bank of China on April 29, who reported EPS of $0.7417 on revenue of $33.09B, compared to forecasts EPS of $0.6343 on revenue of $34.72B.
L’Oreal ADR had matched expectations on April 15 with first quarter EPS of $1.03 on revenue of $9.12B, compared to forecast for EPS of $1.03 on revenue of $9.23B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar